These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38214738)

  • 1. Cardiac effects of 5F-Cumyl-PEGACLONE.
    Esdar N; Pawlik E; Eickhoff SB; Raupach A; Ritz-Timme S; Mayer F
    Int J Legal Med; 2024 May; 138(3):823-831. PubMed ID: 38214738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity profiling of Cumyl-PEGACLONE variants at the CB
    Janssens L; Cannaert A; Connolly MJ; Liu H; Stove CP
    Drug Test Anal; 2020 Sep; 12(9):1336-1343. PubMed ID: 32490586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.
    Ernst L; Langer N; Bockelmann A; Salkhordeh E; Beuerle T
    Forensic Sci Int; 2019 Jan; 294():96-102. PubMed ID: 30497049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia.
    Tiemensma M; Rutherford JD; Scott T; Karch S
    Forensic Sci Med Pathol; 2021 Mar; 17(1):3-9. PubMed ID: 33185835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in early 2017.
    Ernst L; Brandhorst K; Papke U; Altrogge A; Zodel S; Langer N; Beuerle T
    Forensic Sci Int; 2017 Aug; 277():51-58. PubMed ID: 28601726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Synthetic Cannabinoid CUMYL-PEGACLONE in E-Cigarette Oil and Hair.
    Jiao TF; Li YQ; Kang G; Chen SS; Cheng LH
    Fa Yi Xue Za Zhi; 2022 Oct; 38(5):595-600. PubMed ID: 36727175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE.
    Mogler L; Halter S; Wilde M; Franz F; Auwärter V
    Forensic Toxicol; 2019; 37(1):154-163. PubMed ID: 30636984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-One Core.
    Haschimi B; Giorgetti A; Mogler L; Nagy TZ; Kramer S; Halter S; Boros S; Dobos A; Hidvégi E; Auwärter V
    J Anal Toxicol; 2021 Mar; 45(3):277-290. PubMed ID: 32514544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
    Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
    Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
    Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Herbal Mixtures Containing Cumyl-PEGACLONE-Is Inhomogeneity Still an Issue?
    Halter S; Mogler L; Auwärter V
    J Anal Toxicol; 2020 Jan; 44(1):81-85. PubMed ID: 31044247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA.
    Angerer V; Franz F; Moosmann B; Bisel P; Auwärter V
    Forensic Toxicol; 2019; 37(1):186-196. PubMed ID: 30636986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
    Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
    Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Bovens M; Bissig C; Staeheli SN; Poetzsch M; Pfeiffer B; Kraemer T
    Forensic Sci Int; 2017 Dec; 281():98-105. PubMed ID: 29125990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral pharmacology of five novel synthetic cannabinoids.
    Gatch MB; Tourigny A; Shetty RA; Forster MJ
    Behav Pharmacol; 2022 Apr; 33(2&3):175-183. PubMed ID: 33595956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances - A Swedish strategy to protect public health from harm.
    Bäckberg M; Vikingsson S; Strandberg J; Wall S; Åstrand A; Karlsson H; Persson M; Kronstrand R; Green H
    Forensic Sci Int; 2023 Jul; 348():111691. PubMed ID: 37116244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
    Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
    Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.